» Articles » PMID: 28180937

Guidelines for the Management of Postoperative Obstructive Symptoms in Children with Hirschsprung Disease

Overview
Date 2017 Feb 10
PMID 28180937
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Although most children with Hirschsprung disease ultimately do well, many experience a variety of ongoing problems after pull-through surgery. The most common include obstructive symptoms, soiling, enterocolitis and failure to thrive. The purpose of this guideline is to present a rational approach to the management of postoperative obstructive symptoms in children with Hirschsprung disease. The American Pediatric Surgical Association Board of Governors established a Hirschsprung Disease Interest Group. Group discussions, literature review and expert consensus were then used to summarize the current state of knowledge regarding causes, methods of diagnosis, and treatment approaches to children with obstructive symptoms following pull-through for Hirschsprung disease. Causes of obstructive symptoms post-pull-through include mechanical obstruction; persistent or acquired aganglionosis, hypoganglionosis, or transition zone pull-through; internal sphincter achalasia; disordered motility in the proximal intestine that contains ganglion cells; or functional megacolon caused by stool-holding behavior. An algorithm for the diagnosis and management of obstructive symptoms after a pull-through for Hirschsprung disease is presented. A stepwise, logical approach to the diagnosis and management of patients experiencing obstructive symptoms following pull-through for Hirschsprung disease can facilitate treatment. Level of evidence V.

Citing Articles

The efficacy analysis of laparoscopic-assisted Soave procedure for Hirschsprung's disease in neonates and infants within 3 months of age.

Xia R, Ma T, Zhao F, Xiao Y, Feng Y, Li M Sci Rep. 2024; 14(1):31924.

PMID: 39738542 PMC: 11685626. DOI: 10.1038/s41598-024-83422-3.


Postoperative rectal irrigation after laparoscopic Swenson pull-through: is early instrumentation safe?.

Shah N, Maselli K, Kim G, Rollins P, Ehrlich P, Jarboe M World J Pediatr Surg. 2024; 7(4):e000908.

PMID: 39619701 PMC: 11605820. DOI: 10.1136/wjps-2024-000908.


For short-segment Hirschsprung disease, daily trans-anal irrigation before pull-through surgery is necessary?.

Lu H, Tang J, Lu C, Li W, Tang W Pediatr Res. 2024; .

PMID: 39550513 DOI: 10.1038/s41390-024-03730-2.


Long-term outcomes and quality of life in patients with Hirschsprung disease.

Pakarinen M, Mutanen A World J Pediatr Surg. 2024; 7(3):e000859.

PMID: 39410940 PMC: 11474732. DOI: 10.1136/wjps-2024-000859.


Controversies in Hirschsprung surgery.

Xu T, Levitt M, Feng C World J Pediatr Surg. 2024; 7(3):e000887.

PMID: 39346552 PMC: 11429006. DOI: 10.1136/wjps-2024-000887.


References
1.
Dasgupta R, Langer J . Evaluation and management of persistent problems after surgery for Hirschsprung disease in a child. J Pediatr Gastroenterol Nutr. 2007; 46(1):13-9. DOI: 10.1097/01.mpg.0000304448.69305.28. View

2.
Southwell B, Clarke M, Sutcliffe J, Hutson J . Colonic transit studies: normal values for adults and children with comparison of radiological and scintigraphic methods. Pediatr Surg Int. 2009; 25(7):559-72. DOI: 10.1007/s00383-009-2387-x. View

3.
Mueller C, Beaunoyer M, St-Vil D . Topical mitomycin-C for the treatment of anal stricture. J Pediatr Surg. 2010; 45(1):241-4. DOI: 10.1016/j.jpedsurg.2009.10.038. View

4.
Patrus B, Nasr A, Langer J, Gerstle J . Intrasphincteric botulinum toxin decreases the rate of hospitalization for postoperative obstructive symptoms in children with Hirschsprung disease. J Pediatr Surg. 2011; 46(1):184-7. DOI: 10.1016/j.jpedsurg.2010.09.089. View

5.
Zaslavsky C, da Silveira T, Maguilnik I . Total and segmental colonic transit time with radio-opaque markers in adolescents with functional constipation. J Pediatr Gastroenterol Nutr. 1998; 27(2):138-42. DOI: 10.1097/00005176-199808000-00002. View